Cargando…
Oncolytic Viruses: The Power of Directed Evolution
Attempts at developing oncolytic viruses have been primarily based on rational design. However, this approach has been met with limited success. An alternative approach employs directed evolution as a means of producing highly selective and potent anticancer viruses. In this method, diverse viruses...
Autores principales: | Bauzon, Maxine, Hermiston, Terry W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265225/ https://www.ncbi.nlm.nih.gov/pubmed/22312363 http://dx.doi.org/10.1155/2012/586389 |
Ejemplares similares
-
OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution
por: Kuhn, Irene, et al.
Publicado: (2016) -
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
por: Kuhn, Irene, et al.
Publicado: (2008) -
Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy
por: Bauzon, Maxine, et al.
Publicado: (2014) -
Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus
por: Illingworth, Sam, et al.
Publicado: (2017) -
In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity
por: Sim, Derek S., et al.
Publicado: (2021)